About Us

Archives






G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Posted: July 5, 2021 at 1:51 am


RESEARCH TRIANGLE PARK, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 80,400 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Inducement Plan”). The stock options were granted as an inducement material to the new employee’s becoming an employee of G1 in accordance with Nasdaq Listing Rule 5635(c)(4).

The rest is here:
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.